These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 86857)

  • 1. Red-cell-membrane differences in multiple sclerosis are acquired from plasma.
    Seaman GV; Swank RL; Zukoski CF
    Lancet; 1979 May; 1(8126):1139. PubMed ID: 86857
    [No Abstract]   [Full Text] [Related]  

  • 2. Simplified red-cell electrophoretic mobility test for multiple sclerosis.
    Seaman GV; Swank RL; Tamblyn CH; Zukoski CF
    Lancet; 1979 May; 1(8126):1138-9. PubMed ID: 86856
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma origin of red-cell-membrane changes in multiple sclerosis.
    Seaman GV; Swank RL; Tamblyn CH
    Lancet; 1980 Apr; 1(8174):938. PubMed ID: 6103296
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening of children at risk of multiple sclerosis.
    Forrester JA; Smith WJ
    Lancet; 1977 Aug; 2(8035):453-4. PubMed ID: 70661
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory diagnosis of multiple sclerosis.
    Lancet; 1977 Sep; 2(8039):658. PubMed ID: 71468
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrocyte electrophoretic mobility test for multiple sclerosis.
    Hawkins SA; Millar JH
    Lancet; 1979 Jan; 1(8108):165-6. PubMed ID: 84195
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the erythrocyte-UFA (E-UFA) mobility test for the diagnosis of multiple sclerosis.
    Cuypers J; Reddemann H
    J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):995-8. PubMed ID: 7441283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Simplified laboratory test for multiple sclerosis.
    Field EJ; Joyce G
    Lancet; 1976 Aug; 2(7981):367-8. PubMed ID: 60598
    [No Abstract]   [Full Text] [Related]  

  • 9. Red cell electrophoretic mobility test for early diagnosis of multiple sclerosis.
    Tamblyn CH; Swank RL; Seaman GV; Zukoski CF
    Neurol Res; 1980; 2(1):69-83. PubMed ID: 6114451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polystyrene latex particles as indicators of abnormal plasma properties in multiple sclerosis.
    Seaman GV; Swank RL; Tamblyn CH
    Neurology; 1984 Apr; 34(4):547-9. PubMed ID: 6538317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the red blood cell cytopherometric test for the diagnosis of multiple sclerosis.
    Stoof JC; Vrijmoed-de Vries MC; Koetsier JC; Langevoort HL
    Acta Neurol Scand; 1977 Aug; 56(2):170-6. PubMed ID: 899719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease.
    Field EJ; Joyce G; Smith BM
    J Neurol; 1977 Jan; 214(2):113-27. PubMed ID: 64595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of children at risk of multiple sclerosis.
    Field EJ; Joyce G
    Lancet; 1977 Jul; 2(8029):141. PubMed ID: 69222
    [No Abstract]   [Full Text] [Related]  

  • 14. Linoleic-acid-dependent slowing of erythrocyte sedimentation in multiple sclerosis.
    Mayer M
    Prostaglandins Leukot Essent Fatty Acids; 1991 Dec; 44(4):257-8. PubMed ID: 1815242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of red-cell-membrane differences in multiple sclerosis.
    Field EJ; Joyce G
    Lancet; 1979 Nov; 2(8150):1012-3. PubMed ID: 91733
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring changes in the blood of patients with multiple sclerosis.
    Jones R; Capildeo R; Preece AW; Luckman NP; Clifford Rose F
    Prog Brain Res; 1983; 59():333-8. PubMed ID: 6665128
    [No Abstract]   [Full Text] [Related]  

  • 17. Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis.
    Homa ST; Belin J; Smith AD; Monro JA; Zilkha KJ
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):106-10. PubMed ID: 7359147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis.
    Gul S; Smith AD; Thompson RH; Wright HP; Zilkha KJ
    J Neurol Neurosurg Psychiatry; 1970 Aug; 33(4):506-10. PubMed ID: 5505678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The analysis of the red cell unsaturated fatty acid test for multiple sclerosis using laser cytopherometry.
    Jones R; Preece AW; Luckman NP; Forrester JA
    Phys Med Biol; 1983 Oct; 28(10):1145-51. PubMed ID: 6647546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis.
    Cunnane SC; Ho SY; Dore-Duffy P; Ells KR; Horrobin DF
    Am J Clin Nutr; 1989 Oct; 50(4):801-6. PubMed ID: 2801584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.